Real-time enrollment status for this severe hemophilia a clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 10:30 PM UTC
| NCT Number | NCT05935358 |
| Recruiting Status | Recruiting |
| Condition | Severe Hemophilia A |
| Phase | PHASE4 |
| Target Enrollment | 28 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Octapharma |
| Last Updated on CT.gov | May 12, 2026 (May 12, 2026) |
As of August 29, 2026: Clinical trial NCT05935358 is currently recruiting participants. This phase4 study for severe hemophilia a is actively seeking new participants at 1 location across the United States. The study is sponsored by Octapharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05935358 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05935358 was last updated May 12, 2026 (May 12, 2026). HelloStudys verifies this status automatically.